Radioligand assay for gonadotropin-releasing hormone: relative potencies of agonists and antagonists. 1980

M H Perrin, and J E Rivier, and W W Vale

A radioligand assay employing tritiated gonadotropin-releasing hormone, [3H-Pro9]GnRH or [3H-pGlu1]GnRH is used to investigate the binding of GnRH, its agonists, and its antagonists to male rat anterior pituitary homogenates. The tritiated GnRH purified by high pressure liquid chromatography and stored in 10 mM HOAc is stable for binding for at least 14 weeks. It is found that there is at least one high affinity site with an observed Kd of congruent to 2 nM and another low affinity site whose Kd is congruent to 1 microM. Only approximately 25% of the total specific binding is to the low affinity site. At room temperature, the binding is reduced to 50% of that at 0 C, and at 37 C, there is no measurable binding. Bacitracin has no effect on the binding at any temperature. Maximum binding occurs between pH 7.5--8.5. Quantitative relative binding potencies of several agonists and antagonists are given. These potencies closely parallel their biological potencies, but all antagonists have higher absolute binding affinities when compared to their potencies to inhibit GnRH-mediated LH secretion in vitro.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D010903 Pituitary Gland, Anterior The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION. Adenohypophysis,Anterior Lobe of Pituitary,Anterior Pituitary Gland,Lobus Anterior,Pars Distalis of Pituitary,Adenohypophyses,Anterior Pituitary Glands,Anterior, Lobus,Anteriors, Lobus,Lobus Anteriors,Pituitary Anterior Lobe,Pituitary Glands, Anterior,Pituitary Pars Distalis
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3

Related Publications

M H Perrin, and J E Rivier, and W W Vale
January 1987, Hormone research,
M H Perrin, and J E Rivier, and W W Vale
June 1994, Postgraduate medicine,
M H Perrin, and J E Rivier, and W W Vale
November 1983, Journal of medicinal chemistry,
M H Perrin, and J E Rivier, and W W Vale
June 2007, Current opinion in obstetrics & gynecology,
M H Perrin, and J E Rivier, and W W Vale
January 1986, Journal of steroid biochemistry,
M H Perrin, and J E Rivier, and W W Vale
September 2001, Fertility and sterility,
M H Perrin, and J E Rivier, and W W Vale
December 2003, Current opinion in pharmacology,
M H Perrin, and J E Rivier, and W W Vale
September 2008, The New England journal of medicine,
M H Perrin, and J E Rivier, and W W Vale
December 2008, The New England journal of medicine,
Copied contents to your clipboard!